Keyphrases
Acute Respiratory Distress Syndrome
16%
Antibiotic Resistance
17%
Antimicrobial Resistance
25%
Biofilm
12%
Clinical Characterization
11%
COVID-19
55%
COVID-19 Patients
21%
Critically Ill Patients
23%
Duty Cycle
12%
Emerging Infections
20%
Endotracheal Tube
25%
Endotracheal Tube Biofilm
16%
Escherichia Coli
11%
ESKAPE
15%
Evolution of Antimicrobial Resistance
13%
Expiratory Flow
14%
High-income Countries
22%
High-performance Liquid Chromatography Method
15%
Hospitalized Patients
36%
Intensive Care Unit
38%
International Cohort
26%
Invasive Mechanical Ventilation
11%
Klebsiella Pneumoniae (K. pneumoniae)
12%
Lima
26%
Linezolid
31%
Low-middle Income Countries
26%
Mechanical Ventilation
36%
Mechanically Ventilated
14%
Methicillin-resistant Staphylococcus Aureus
25%
Microorganisms
13%
Mucus
14%
Mucus Clearance
20%
Odds Ratio
11%
Patients with COVID-19
35%
Peru
42%
Peruvian
19%
Pneumonia
22%
Porcine Model
16%
Positive End-expiratory Pressure
21%
Pseudomonas Aeruginosa (P. aeruginosa)
26%
Pulmonary Tissue
15%
Resistance Level
21%
Serratia Marcescens
11%
Severe Acute Respiratory Syndrome
20%
Severe COVID-19
15%
Severe Pneumonia
15%
Trendelenburg
13%
Trendelenburg Position
23%
Vancomycin
24%
Ventilator-associated Pneumonia
36%
Medicine and Dentistry
2 Propanol
7%
Acute Kidney Injury
7%
Acute Renal Failure
7%
Acute Respiratory Distress Syndrome
15%
Antibiogram
9%
Antibiotic Resistance
19%
Apoplexy
14%
Artificial Respiration
38%
Assisted Ventilation
7%
Cardiovascular Disease
7%
Chlorhexidine
7%
Cohort Analysis
7%
Cohort Effect
7%
Colistimethate
9%
Community-Acquired Pneumonia
7%
Comorbidity
10%
Continuous Positive Airway Pressure
14%
COVID-19
100%
Dengue Fever
7%
Diagnostic Marker
7%
Disinfectant Agent
7%
Expiratory Flow
12%
Extended Spectrum Beta Lactamase
7%
Feces
7%
Gram-Negative Bacteria
7%
In Vitro
7%
Infection
26%
Intensive Care
9%
Intensive Care Unit
40%
Klebsiella pneumoniae
7%
Low and Middle Income Countries
22%
Mucociliary Clearance
7%
Mucus
16%
Nasal Cannula
7%
Neurologic Finding
7%
Neuromuscular Blocking Agent
7%
Observational Study
18%
Polyurethan
15%
Polyvinylchloride
7%
Pseudomonas aeruginosa
22%
Respiratory Failure
7%
Respiratory System
8%
Rib Cage
7%
Salmonella
7%
Secretion (Process)
14%
Trachea
7%
Trachea Injury
7%
Trendelenburg Position
20%
Typhoid Fever
7%
Ventilator-Associated Pneumonia
27%
Pharmacology, Toxicology and Pharmaceutical Science
2 Propanol
7%
Acute Kidney Failure
9%
Adult Respiratory Distress Syndrome
17%
Antibiotic Resistance
31%
Antiinfective Agent
6%
Antimicrobial Resistance
23%
Blood Clotting Disorder
7%
Case Fatality Rate
9%
Cephalosporin Derivative
6%
Cerebrovascular Accident
7%
Chlorhexidine
7%
Clinical Feature
9%
Cohort Study
7%
Community Acquired Pneumonia
7%
Comorbidity
14%
Coronavirinae
15%
Coughing
7%
Dengue
7%
Disease
17%
Diseases
7%
Disinfectant Agent
7%
Dyspnea
10%
Enterobacteriales
7%
Epidemic
7%
Epidemiology
7%
Escherichia coli
9%
Extended Spectrum Beta Lactamase
7%
High Performance Liquid Chromatography
16%
Hospital Mortality
12%
Infection
27%
Klebsiella pneumoniae
10%
Linezolid
15%
Liver Injury
7%
Lung Embolism
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Microorganism
11%
Minimum Inhibitory Concentration
7%
Neurological Complication
5%
Neuromuscular Blocking Agent
7%
Penicillinase
6%
Pharmacokinetics
7%
Polyurethan
7%
Prevalence
29%
Respiratory Tract Disease
7%
Rhinorrhea
7%
SARS Coronavirus
12%
Serratia marcescens
11%
Sore Throat
7%
Vancomycin
15%
Wheezing
7%